Bupivacaine in epidural catheter — Competitive Intelligence Brief

Bupivacaine in epidural catheter (Bupivacaine in epidural catheter) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Anesthesia.

marketed Local anesthetic Voltage-gated sodium channels Anesthesia Small molecule

Target snapshot

Bupivacaine in epidural catheter (Bupivacaine in epidural catheter) — Odense University Hospital. Bupivacaine blocks sodium channels in nerve fibers, preventing the initiation and propagation of action potentials to produce local anesthesia.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Bupivacaine in epidural catheter TARGET	Bupivacaine in epidural catheter	Odense University Hospital	marketed	Local anesthetic	Voltage-gated sodium channels
Bupivacaine supraclavicular block	Bupivacaine supraclavicular block	Jose Soberon, MD	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Nerve block with Lidocain	Nerve block with Lidocain	Tehran University of Medical Sciences	marketed	Local anesthetic	Voltage-gated sodium channels
lithium plus carbamazepine	lithium plus carbamazepine	University of Sao Paulo	marketed	Mood stabilizer combination	Lithium: inositol monophosphatase and GSK-3β; Carbamazepine: voltage-gated sodium channels
bupivacaine/ neostigmine.	bupivacaine/ neostigmine.	Ain Shams University	marketed	Local anesthetic combination	Voltage-gated sodium channels (bupivacaine); acetylcholinesterase (neostigmine)
Ropivacaine concentration low	Ropivacaine concentration low	Oslo University Hospital	marketed	Local anesthetic	Voltage-gated sodium channels
Bupivacaine low dose	Bupivacaine low dose	Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias	marketed	Local anesthetic	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

1. University of California, San Diego · 3 drugs in this class
2. Durect · 3 drugs in this class
3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
4. Wake Forest University Health Sciences · 3 drugs in this class
5. Medical University of Vienna · 3 drugs in this class
6. Imperial College London · 2 drugs in this class
7. Hvidovre University Hospital · 2 drugs in this class
8. Innocoll · 2 drugs in this class
9. George Washington University · 2 drugs in this class
10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class